Dr. Amit Kumar Rauniyar, MD

Dr. Rauniyar practices at M Health Fairview Southdale Hospital in Edina, Minnesota, part of M Health Fairview.

Dr. Rauniyar's NPI, 1326378225, was assigned on December 28, 2009. Dr. Rauniyar holds Minnesota license 54862.

Dr. Rauniyar's primary practice is M Health Fairview Southdale Hospital, at 6401 France Avenue South, Edina, MN 55435 in Hennepin County. The practice phone is (952) 924-5000.

Dr. Rauniyar's primary practice is M Health Fairview Southdale Hospital in Edina, Minnesota, part of M Health Fairview. Dr. Rauniyar is also affiliated with M Health Fairview Ridges Hospital. The medical group on file is Fairview Health Services. Dmand AI also links Dr. Rauniyar to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rauniyar practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Rauniyar's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Rauniyar's licenses on file in 3 states: Minnesota, Illinois and Wisconsin.

CMS data shows 554 Medicare services from Dr. Rauniyar across 6 procedure codes in 2024, for 225 Medicare patients. Medicare paid $42,037 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Dr. Rauniyar in 2024. The largest group is 85 and over, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rauniyar's median patient age at 73, with 54% women.

In 2024, Dr. Rauniyar wrote 287 Medicare Part D claims for 109 patients. 82% of them were for generic drugs. CMS names the drug for 97 of them, across 7 drugs with 11 or more claims each, at $10,893 in total drug cost. In 2023, CMS named 157 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Rauniyar for performance year 2024, reported as part of a group. Dr. Rauniyar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Rauniyar from 2 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $24.